Two Sigma Advisers
RVLP

Two Sigma Advisers’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Two Sigma Advisers’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,100
Closed -$15.8K – 2802
2022
Q4 		$15.8K Hold
14,100
– – ﹤0.01% 2442
2022
Q3 		$30K Sell
14,100
-3,300
-19% -$6.41K ﹤0.01% 2417
2022
Q2 		$24K Sell
17,400
-400
-2% -$579 ﹤0.01% 2540
2022
Q1 		$30K Sell
17,800
-45,400
-72% -$64.9K ﹤0.01% 2638
2021
Q4 		$68K Buy
+63,200
New +$103K ﹤0.01% 2454

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Two Sigma Advisers's RVLP Position: Q1 2023 in Review

Two Sigma Advisers sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2023, closing a stake of 14,100 shares — an estimated $15.8K sold.

Two Sigma Advisers first reported a position in RVLP in Q4 2021 and held it in 5 quarters. The position peaked at $68K in Q4 2021. 41 funds tracked by Wall St. Rank hold RVLP as of Q1 2023.

  • Two Sigma Advisers reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 14,100 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2023, an estimated $15.8K.
  • Two Sigma Advisers first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and held it in 5 quarters.
  • Two Sigma Advisers's RVL Pharmaceuticals plc Ordinary Shares position peaked at $68K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.